Kiniksa Pharmaceuticals International, plc KNSA Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's intangibles (net)?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported intangibles (net) of $15M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's intangibles (net) changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's intangibles (net) decreased by 6.3% year-over-year, from $16M to $15M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.